NasdaqGM:ALVOBiotechs
Assessing Alvotech (ALVO) Valuation After FDA Setback And Securities Investigation Concerns
What triggered the sharp move in Alvotech?
Alvotech (ALVO) shares fell sharply after reports of potential securities claims tied to allegedly misleading business information, together with an FDA complete response letter citing deficiencies at the company’s Reykjavik manufacturing facility.
See our latest analysis for Alvotech.
Those legal and regulatory setbacks land on top of a weak backdrop, with a 90 day share price return of a 39.73% decline and a 1 year total shareholder return of a...